Engineers Gate Manager LP Lowers Stock Position in Pediatrix Medical Group, Inc. $MD

Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 60.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,871 shares of the company's stock after selling 77,533 shares during the quarter. Engineers Gate Manager LP owned approximately 0.06% of Pediatrix Medical Group worth $1,263,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of Pediatrix Medical Group during the second quarter worth about $347,383,000. Wasatch Advisors LP acquired a new stake in Pediatrix Medical Group in the first quarter valued at about $43,861,000. Bank of New York Mellon Corp acquired a new stake in Pediatrix Medical Group in the second quarter valued at about $14,297,000. Rockefeller Capital Management L.P. boosted its holdings in Pediatrix Medical Group by 814.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company's stock valued at $12,713,000 after purchasing an additional 529,367 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in Pediatrix Medical Group in the 2nd quarter valued at approximately $12,668,000. Hedge funds and other institutional investors own 97.71% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on MD shares. Wall Street Zen upgraded Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a research report on Sunday, September 13th. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $25.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Pediatrix Medical Group from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, September 9th. Truist Financial upped their price target on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a "hold" rating in a research note on Tuesday, July 14th. Finally, Jefferies Financial Group cut shares of Pediatrix Medical Group from a "buy" rating to a "hold" rating and upped their price target for the stock from $27.00 to $28.00 in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $26.60.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $25.52 on Friday. The company has a 50-day simple moving average of $26.37 and a 200-day simple moving average of $23.80. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $2.07 billion, a PE ratio of 12.21 and a beta of 0.64. Pediatrix Medical Group, Inc. has a 12 month low of $15.69 and a 12 month high of $27.94.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The company had revenue of $487.78 million during the quarter, compared to the consensus estimate of $478.49 million. During the same period in the previous year, the firm posted $0.53 EPS. Pediatrix Medical Group's revenue was up 4.1% on a year-over-year basis. On average, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc is a physician-led healthcare services company that provides specialized medical care for women, infants and children. The company partners with hospitals and health systems to deliver care through physician practices, neonatal intensive care units and other hospital-based programs.

Its services include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric hospital medicine and other pediatric subspecialties. Pediatrix physicians care for patients before, during and after childbirth, as well as children requiring specialized or critical care.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.